Search for: "TEVA PHARMACEUTICAL INDUSTRIES LIMITED"
Results 121 - 136
of 136
Sorted by Relevance
|
Sort by Date
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
5 Apr 2012, 11:54 am
Teva Pharmaceuticals USA, Inc., 2011 WL 4025734, at *3 (S.D. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition:… [read post]
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
13 Apr 2014, 8:59 am
Teva Canada Ltd. v. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
28 Mar 2008, 6:00 am
– GIs and the wine industry: (Canadian Trademark Blog) ChinaWorkTools: ‘We won the judgement but it did no good’ Part II: (IP Dragon),How should China spend its extra Yuan on IPR enforcement? [read post]
22 Nov 2010, 11:02 am
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for Thirty-Six ProfessorsPetitioner's reply Title: Tiffany (NJ) Inc. v. eBayDocket: 10-300Issue(s):… [read post]
23 Apr 2014, 8:50 am
Owens, 13-719 (granted at the April 4 Conference, relisted once); Teva Pharmaceuticals USA, Inc. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
15 Oct 2018, 7:05 am
Justice Kavanaugh being seated prior to the second week of oral arguments in October means that most of the cases on the docket in the October Term will be heard by a complete Court of 9 Justices; thus avoiding the dreaded 4-4 split. [read post]
